Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Frances Arnold Director
Sold on a plan
$33.93K 112 at 302.99
0.6%
Planned (10b5-1)
2 Mar 2026
Russell Schundler General Counsel
Sold on a plan
$32.81K 1,073 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Robert Allen John Chief Revenue Officer
Sold on a plan
$31.33K 3,964 at 7.90
4.4%
Planned (10b5-1)
2 Mar 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$30.86K 417 at 74.00
0.4%
Planned (10b5-1)
2 Mar 2026
John Thomas Director
Sold on a plan
$28.96K 10,000 at 2.90
2.0%
Planned (10b5-1)
2 Mar 2026
Mark R Szczepaniak Chief Financial Officer · indirect
Sold on a plan
$28.82K 1,573 at 18.32
2.1%
Planned (10b5-1)
2 Mar 2026
Michael Olsen General Counsel and CCRO
Sold on a plan
$28.00K 20,000 at 1.40
1.6%
Planned (10b5-1)
2 Mar 2026
David Michael Barrett Chief Executive Officer · indirect
Sold on a plan
$27.00K 30,000 at 0.90
2.3%
Planned (10b5-1)
2 Mar 2026
Karen Akinsanya See Remarks
Sold on a plan
$26.45K 2,206 at 11.99
3.0%
Planned (10b5-1)
2 Mar 2026
Craig Saldanha Chief Product Officer
Sold on a plan
$26.14K 1,200 at 21.78
0.5%
Planned (10b5-1)
2 Mar 2026
Scott Moomaw Chief Commercial Officer
Sold on a plan
$25.29K 827 at 30.58
0.4%
Planned (10b5-1)
2 Mar 2026
Mike Zoi 10% owner · indirect
Sold on a plan
$24.31K 6,500 at 3.74
0.5%
Planned (10b5-1)
2 Mar 2026
Sold on a plan 4×
$23.76K 4,799 at 4.95
3.2%
Planned (10b5-1)
2 Mar 2026
Monica Raines EVP, CCO and Quality Officer
Sold on a plan
$22.88K 224 at 102.15
1.6%
Planned (10b5-1)
2 Mar 2026
Randall K Fields Chief Executive Officer · indirect
Sold on a plan
$21.88K 2,500 at 8.75
2.5%
Planned (10b5-1)
2 Mar 2026
Jason Adair Chief Business Officer
Sold on a plan
$21.07K 689 at 30.58
0.3%
Planned (10b5-1)
2 Mar 2026
Robert J Mears Chief Technology Officer
Sold on a plan 4×
$19.70K 3,979 at 4.95
2.3%
Planned (10b5-1)
2 Mar 2026
Sold on a plan
$16.91K 1,500 at 11.27
11.7%
Planned (10b5-1)
2 Mar 2026
Kristen N Sieffert President
Sold on a plan
$14.12K 750 at 18.82
0.9%
Planned (10b5-1)
2 Mar 2026
Jared Oasheim Chief Financial Officer
Sold on a plan
$13.78K 1,744 at 7.90
1.8%
Planned (10b5-1)
2 Mar 2026
Dana Boyle Chief Accounting Officer
Sold on a plan
$13.61K 445 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Dmitry Zamansky Chief Product & Tech. Officer
Sold on a plan
$13.47K 2,472 at 5.45
1.2%
Planned (10b5-1)
2 Mar 2026
Thomas E Chorman Director
Sold on a plan
$12.95K 50 at 259.00
0.4%
Planned (10b5-1)
2 Mar 2026
David R Epstein Director
Sold on a plan
$12.67K 250 at 50.69
1.0%
Planned (10b5-1)
2 Mar 2026
Andrew E Grimmig Chief Legal Officer
Sold on a plan
$10.31K 1,000 at 10.31
1.0%
Planned (10b5-1)
2 Mar 2026
Natalia Mirgorodskaya See Remarks
Sold on a plan
$10.15K 390 at 26.02
1.1%
Planned (10b5-1)
2 Mar 2026
Paul Verrastro Chief Mktg & Strat Officer
Sold on a plan
$10.15K 1,284 at 7.90
2.1%
Planned (10b5-1)
2 Mar 2026
Philip B. Adamson Chief Medical Officer
Sold on a plan
$9.97K 1,262 at 7.90
2.0%
Planned (10b5-1)
2 Mar 2026
Alina Kerdman SVP, Controller & CAO
Sold on a plan
$9.54K 151 at 63.16
19.5%
Planned (10b5-1)
2 Mar 2026
Sarah Krepp Chief Human Resource Officer
Sold on a plan
$8.44K 276 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Richard D Gebert Director
Sold on a plan
$8.24K 500 at 16.47
1.3%
Planned (10b5-1)
2 Mar 2026
Nasym Afsari General Counsel and Secretary
Sold on a plan
$6.00K 200 at 30.00
0.1%
Planned (10b5-1)
2 Mar 2026
Kimberly G. Stith SVP - Chief HR Officer
Sold on a plan
$5.11K 21 at 243.13
0.4%
Planned (10b5-1)
2 Mar 2026
David L. Reed EVP & CFO
Sold on a plan
$5.10K 21 at 242.65
0.2%
Planned (10b5-1)
2 Mar 2026
William O'Dowd IV Chief Executive Officer
Bought on a plan
$4.99K 3,100 at 1.61
0.7%
Bought on a plan
2 Mar 2026
James Edward Sklar EVP, Gen Counsel & Secretary
Sold on a plan
$4.85K 3,734 at 1.30
1.4%
Planned (10b5-1)
2 Mar 2026
Lauren Freemen-Bosworth EVP/Gen Counsel & Corp Sec
Sold on a plan
$2.87K 271 at 10.60
0.9%
Planned (10b5-1)
2 Mar 2026
Lori A Conkling Director
Bought on a plan
$1.73K 25 at 69.21
1.0%
Bought on a plan
2 Mar 2026
Kevin J. McCallion SVP, Products and Production
Sold on a plan
$49.00 7 at 7.00
0.0%
Planned (10b5-1)
27 Feb 2026
Innovex Co-Invest Fund, L.p. Director · indirect
Sold on a plan 6×
$162.61M 6,612,500 at 24.59
100.0%
Sold half or more
27 Feb 2026
Susan J Li Chief Financial Officer · indirect
Sold on a plan 10×
$36.47M 56,571 at 644.70
100%
Sold half or more
27 Feb 2026
Reshma Kewalramani CEO & President
Sold on a plan 13×
$19.74M 40,000 at 493.47
28.9%
Planned (10b5-1)
27 Feb 2026
Bought on a plan
$10.53M 147,000 at 71.63
0.3%
Bought on a plan
27 Feb 2026
R. Hewitt Pate Chief Legal Officer
Sold on a plan 4×
$6.60M 35,475 at 186.06
80.6%
Sold half or more
27 Feb 2026
Spencer Adam Neumann Chief Financial Officer
Sold on a plan 2×
$5.47M 57,260 at 95.50
43.7%
Planned (10b5-1)
27 Feb 2026
Eimear P Bonner Chief Financial Officer
Sold on a plan 4×
$5.28M 28,400 at 186.06
77.1%
Sold half or more
27 Feb 2026
Wajid Ali EVP & Chief Financial Officer
Sold on a plan 13×
$3.66M 5,302 at 691.13
7.4%
Planned (10b5-1)
27 Feb 2026
Eric J Cremers Executive Chairman
Sold on a plan
$3.63M 169,200 at 21.44
19.3%
Planned (10b5-1)
27 Feb 2026
Daniel Janney Director · indirect
Sold on a plan 2×
$3.25M 11,803 at 275.59
13.9%
Planned (10b5-1)
27 Feb 2026
Olivier Rabiller President & CEO
Sold on a plan
$2.93M 144,000 at 20.32
13.7%
Planned (10b5-1)
Showing 16,101–16,150 of 23,258. ← Newer Page 323 of 466 Older →